REG-BARCLAYS PLC Form 8.3 - Meggitt plc
18/01/2022 13:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220118:nBw1B3FC4a&default-theme=true
Form 8.3 - Meggitt plc
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose MEGGITT PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 17 January 2022
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 42,218,559 5.40% 8,995,170 1.15%
(2) Cash-settled derivatives:
136,442 0.02% 30,684,765 3.92%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 42,355,001 5.42% 39,679,935 5.07%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other
employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
5p ordinary Purchase 145 7.4500 GBP
5p ordinary Purchase 241 7.4280 GBP
5p ordinary Purchase 384 7.4260 GBP
5p ordinary Purchase 388 7.4460 GBP
5p ordinary Purchase 397 7.4430 GBP
5p ordinary Purchase 411 7.4300 GBP
5p ordinary Purchase 586 7.4240 GBP
5p ordinary Purchase 1,416 7.4420 GBP
5p ordinary Purchase 1,552 7.4455 GBP
5p ordinary Purchase 2,494 7.4447 GBP
5p ordinary Purchase 2,506 7.4244 GBP
5p ordinary Purchase 3,716 7.4267 GBP
5p ordinary Purchase 15,363 7.4386 GBP
5p ordinary Purchase 15,542 7.4277 GBP
5p ordinary Purchase 26,429 7.4220 GBP
5p ordinary Purchase 60,000 7.4202 GBP
5p ordinary Purchase 190,000 7.4402 GBP
5p ordinary Purchase 1,940,000 7.4000 GBP
5p ordinary Sale 10 7.4440 GBP
5p ordinary Sale 58 7.4480 GBP
5p ordinary Sale 145 7.4500 GBP
5p ordinary Sale 301 7.4240 GBP
5p ordinary Sale 384 7.4260 GBP
5p ordinary Sale 388 7.4460 GBP
5p ordinary Sale 397 7.4430 GBP
5p ordinary Sale 439 7.4431 GBP
5p ordinary Sale 760 7.4346 GBP
5p ordinary Sale 793 7.4244 GBP
5p ordinary Sale 1,278 7.4510 GBP
5p ordinary Sale 1,416 7.4420 GBP
5p ordinary Sale 1,608 7.4326 GBP
5p ordinary Sale 1,865 7.4300 GBP
5p ordinary Sale 2,344 7.4404 GBP
5p ordinary Sale 2,843 7.4502 GBP
5p ordinary Sale 2,996 7.4277 GBP
5p ordinary Sale 4,302 7.4469 GBP
5p ordinary Sale 4,562 7.4429 GBP
5p ordinary Sale 5,488 7.4352 GBP
5p ordinary Sale 5,588 7.4408 GBP
5p ordinary Sale 8,486 7.4354 GBP
5p ordinary Sale 18,184 7.4390 GBP
5p ordinary Sale 18,658 7.4243 GBP
5p ordinary Sale 44,719 7.4220 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
5p ordinary SWAP Long 110 7.4440 GBP
5p ordinary SWAP Long 5,546 7.4341 GBP
5p ordinary SWAP Long 6,472 7.4389 GBP
5p ordinary SWAP Long 6,955 7.4326 GBP
5p ordinary SWAP Long 10,881 7.4216 GBP
5p ordinary SWAP Long 14,269 7.4215 GBP
5p ordinary SWAP Long 29,456 7.4220 GBP
5p ordinary SWAP Short 1,433 7.4430 GBP
5p ordinary CFD Short 2,718 7.4320 GBP
5p ordinary SWAP Short 5,424 7.4219 GBP
5p ordinary SWAP Short 6,146 7.4333 GBP
5p ordinary SWAP Short 8,600 7.4367 GBP
5p ordinary SWAP Short 15,363 7.4386 GBP
5p ordinary SWAP Short 26,017 7.4220 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state
“none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 18 Jan 2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does not need to be
included, provided contact information has been provided to the Panel’s
Market Surveillance Unit.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=52564149&newsitemid=20220118005696&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=19502783184ab7a97325f008ffc403ae)
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20220118005696/en/
(https://www.businesswire.com/news/home/20220118005696/en/)
BARCLAYS PLC
Copyright Business Wire 2022Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement